Recombinant subunits of SARS-CoV-2 spike protein as vaccine candidates to elicit neutralizing antibodies.

Noorabad Ghahroodi, Faezeh; Khalili, Saeed; Rasaee, Mohammad Javad

Noorabad Ghahroodi, Faezeh; Khalili, Saeed; Rasaee, Mohammad Javad.

Afiliação

Noorabad Ghahroodi F; Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Khalili S; Department of Biology Sciences, Shahid Rajaee Teacher Training University, Tehran, Iran.
Rasaee MJ; Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

J Clin Lab Anal ; 36(5): e24328, 2022 May.

Article em En | MEDLINE | ID: mdl-35349744

Assuntos

Vacinas contra COVID-19; COVID-19; Glicoproteína da Espícula de Coronavírus; Animais; Anticorpos Neutralizantes/imunologia; Anticorpos Antivirais/imunologia; COVID-19/prevenção & controle; Vacinas contra COVID-19/imunologia; Humanos; Camundongos; Coelhos; Proteínas Recombinantes/imunologia; SARS-CoV-2; Glicoproteína da Espícula de Coronavírus/imunologia

Palavras-chave

SARS-CoV-2; in silico; neutralizing antibody; spike protein; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2022

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google